SIRT1) and non-genomic pathways (i.e., ER signalling), which will in turn improve cognitive function, but will also counteract insulin resistance in T2DM, as previously discussed in our first report of this study [18]. The gene discussed is SIRT1; the disease is Insulin resistance.